Wize Pharma (QB) Stock Price

0.0259 (15.14%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Wize Pharma Inc (QB) WIZP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0259 15.14% 0.197 13:09:36
Close Price Low Price High Price Open Price Previous Close
0.197 0.196 0.197 0.196 0.1711
Bid Price Ask Price Spread News
0.16 0.197 0.037 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 3,000 $ 0.196917 $ 591 6,045 0.061 - 0.40
Last Trade Time Type Quantity Stock Price Currency
13:09:36 2,750 $ 0.197 USD

Wize Pharma (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.21M 16.30M 6.30M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
705.00 $ - 0.00% - -

more financials information »

Wize Pharma (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical WIZP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.160.1970.160.19065735,1770.03723.13%
1 Month0.1550.1970.150.17342524,7620.04227.1%
3 Months0.220.220.1050.17342989,641-0.023-10.45%
6 Months0.1470.250.0730.183755416,6630.0534.01%
1 Year0.250.400.0610.186408519,056-0.053-21.2%
3 Years0.256.100.03250.653526416,002-0.053-21.2%
5 Years0.256.100.03250.653526416,002-0.053-21.2%

Wize Pharma (QB) Description

Wize Pharma is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize Pharma has inlicensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of Dry Eye Syndrome, and other ophthalmological illnesses, including Sjorgen's Syndrome and Conjunctivochalasis.

Your Recent History
Wize Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.